B. K. Komyakov

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

Joaquim Bellmunt, Christine Théodore, T. Demkov et al. · Journal of Clinical Oncology · 2009 · 779 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama et al. · The Lancet · 2025 · 47 citations · Full text

Medicine, Oncology, Urology +13

Detection of DNA viruses in prostate cancer

Vitaly Smelov, Davit Bzhalava, Laila Sara Arroyo Mühr et al. · Scientific Reports · 2016 · 35 citations · Full text

Life Sciences, Molecular Biology, Urology +17

Ureteral substitution with appendix

B. K. Komyakov, V.А. Ochelenko, Maksim Shevnin · International Journal of Urology · 2020 · 30 citations

Medicine, Surgery, Urology +17